Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06194305 · ClinicalTrials.gov registry record · Phase 2
Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics
A Phase 2 study of Tourette Syndrome and Persistent Tic Disorder, sponsored by University of Minnesota.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 100
- Enrollment target
- 2
- Study locations
NCT06194305 is a Phase 2 study of Tourette Syndrome and Persistent Tic Disorder that is actively recruiting participants, run by University of Minnesota. The registered enrollment target is 100 participants, above the 84-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (19% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT06194305, a Phase 2 study of Tourette Syndrome and Persistent Tic Disorder, is actively recruiting participants, sponsored by University of Minnesota.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 100 participants
- Enrollment target
- 2
- Study locations
Study Summary
Tourette Syndrome and Persistent Motor/Vocal Tic Disorder affect 1-3% of youth and can be associated with impaired functioning, emotional and behavioral problems, physical pain, diminished quality of life, and peer victimization. Chronic tics are the primary symptom. Comprehensive Behavioral Intervention for Tics (CBIT) is a manualized treatment focused on tic management skills. During the core CBIT procedure, competing response training, patients learn to inhibit tics by engaging in a competing motor action. The overall objective of this study is to identify bio-behavioral predictors and correlates of response and the most potent aspects of CBIT. Participants with chronic tics will complete a manualized course of 8-session CBIT. Neural, behavioral, psychosocial, and global functioning will be assessed longitudinally to examine predictors and correlates of response. CBIT sessions will be video recorded. CBIT process will be measured with a video-based behavioral coding scheme that will be refined and validated during years 1-2 using archival CBIT videos
Conditions Studied
Interventions
- OTHER CBIT
Study Locations (2)
California
- University of California - San Diego
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-04-25 |
| Est. Completion | 2029-02-19 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06194305
The ClinicalTrials.gov registry entry for NCT06194305 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 84-participant average among 33 other Tourette Syndrome trials with a reported enrollment target (19% higher). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Tourette Syndrome appearing as the primary indexed condition, and to 1 intervention - of which CBIT is the first listed.
NCT06194305 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06194305 about?
NCT06194305 is a clinical study titled "Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics". Tourette Syndrome and Persistent Motor/Vocal Tic Disorder affect 1-3% of youth and can be associated with impaired functioning, emotional and behavioral problems, physical pain, diminished quality of life, and peer victimization. Chronic tics are the primary symptom. Comprehensive Behavioral Interve...
What is the current status of trial NCT06194305?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 100 participants. The study started on 2024-04-25. Estimated completion is 2029-02-19.
What conditions does trial NCT06194305 study?
This clinical trial studies the following conditions: Tourette Syndrome, Persistent Tic Disorder.
What interventions are being tested in trial NCT06194305?
The interventions under investigation include: CBIT (OTHER).
Who is sponsoring clinical trial NCT06194305?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06194305 being conducted?
This trial has 2 study locations across California, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Tourette Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CBIT+TMS R33 Phase
RECRUITING · Phase 2
-
Efficacy and Safety of Gemlapodect (NOE-105) in Adults and Adolescents With Tourette Syndrome
ACTIVE NOT RECRUITING · Phase 2
-
Pramipexole Pilot Phase II Study in Children and Adolescents With Tourette Disorder According to DSM-IV Criteria
COMPLETED · Phase 2
-
Transcranial Magnetic Stimulation (TMS) for Individuals With Tourette's Syndrome
COMPLETED · Phase 2
-
Cognitive Behavior Therapy and Habit Reversal Training for the Treatment of Chronic Tic Disorders in Children
COMPLETED · Phase 2
-
Sensorimotor and Psychosocial Trajectories in Adolescents With Tic Disorder
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.